SRTA Strata Critical Medical, Inc.
IndustrialsAs of 2026-05-25
Valuation
View DetailsP/E (TTM)
8.54
PEG
0.03
P/B
1.83
P/S
2.09
EV/EBITDA
-85.19
DCF Value
$-20.37
FCF Yield
-10.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
20.5%
Operating Margin
-6.0%
Net Margin
20.0%
ROE
19.0%
ROA
15.5%
ROIC
-4.9%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 null | $67.4M | $2.5M | $— |
| Q4 null | $66.8M | $-5.4M | $— |
| FY null | $197.1M | $-15.6M | $— |
| Q3 null | $49.3M | $57.4M | $— |
Analyst Ratings
View AllConsensus
Buy
Target (Consensus)
$7.25
Target (Median)
$7.25
Target Range
$7.25 - $7.25
Trading Activity
Insider Trades
View AllCompany Info
Sector
Industrials
Industry
Airlines, Airports & Air Services
Country
US
Exchange
—
Beta
2.15
Strata Critical Medical, Inc. provides time critical logistics solutions and specialized medical services to healthcare providers across the United States. The company operates as both an air and ground transporter of human organs for transplant. The company was formerly known as Blade Air Mobility, Inc. and change its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.